Integra LifeSciences Holdings Corp. (IART)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Integra LifeSciences Holdings Corp. (IART)
Company Performance

Current Price

as of Oct 16, 2024

$19.80

P/E Ratio

67.10

Market Cap

$1.54B

Description

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Metrics

Overview

  • HQPrinceton, NJ
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerIART
  • Price$19.8+1.49%

Trading Information

  • Market Cap$1.54B
  • Float83.88%
  • Average Daily Volume (1m)956,107
  • Average Daily Volume (3m)1,140,980
  • EPS$0.30

Company

  • Revenue$1.57B
  • Rev Growth (1yr)9.68%
  • Net Income-$12.40M
  • Gross Margin55.59%
  • EBITDA Margin17.23%
  • EBITDA$72.03M
  • EV$3.97B
  • EV/Revenue2.53
  • P/E67.10
  • P/S0.98
  • P/B1.00